NeurologyLive Friday 5 — April 30, 2021

April 30, 2021
NeurologyLive Staff

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending April 30, 2021.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Peer Exchange: Genetic Testing for Patients with ALS

Experts in neurology—Richard S. Bedlack, MD, PhD, MS; Ammar Al-Chalabi, MB, ChB, PhD; Jinsy A. Andrews, MD, MSc; and Jeremy M. Schefner, MD, PhD—give insight into recent advancements in genetic testing for amyotrophic lateral sclerosis (ALS) and discuss what factors to consider when offering it to patients in this Peer Exchange, "Progress in the Treatment of Amyotrophic Lateral Sclerosis (ALS)."

2: Mind Moments Episode 35: Highlights From the AAN Annual Meeting

"Mind Moments," a podcast from NeurologyLive, brings you exclusive interviews with Stephanie Nahas-Grieger, MD; Bruce Cree, MD, PhD, MAS; Sana Somani, MD, MBBS; Hubert Fernandez, MD; Daniel Ontaneda, MD, PhD; and Richard Gershon, PhD.

3: NeuroVoices: Neal Parikh, MD, MS, on Racial Disparities in Post-Stroke Smoking Cessation

The assistant professor of neurology at the Weill Cornell Brain and Spine Center discussed his presentation at the 2021 American Academy of Neurology Annual Meeting evaluating racial disparities in smoking cessation among stroke survivors.

4: Neurosurgery and Parkinson Disease: Past, Present, and Future of Deep Brain Stimulation

Atom Sarkar, MD, PhD, urges that surgical care for PD is safe and effective, and should no longer be treated as a consideration of last resort, but as a treatment option discussed early in the disease course with the patient and their family.

5: Peer Exchange: Early, Aggressive Therapy for Relapsing-Remitting MS

In this Peer Exchange, "Strategies in Treating Relapsing-Remitting Multiple Sclerosis," experts Scott Newsome, DO, MSCS, FAAN; Patricia K. Coyle, MD; Robert Fox, MD; and Clyde E. Markowitz, MD, discuss the rationale for initiating aggressive therapy early on to treat patients who present with relapsing-remitting multiple sclerosis.